Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Eason

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancer Research|September 17, 2016
Molecular or Metabolic Reprograming: What Triggers Tumor Subtypes?Katherine Eason, Anguraj Sadanandam
BMC Bioinformatics|May 27, 2018
polyClustR: defining communities of reconciled cancer subtypes with biological and prognostic significanceKatherine Eason, Gift Nyamundanda, Anguraj Sadanandam
Cancers|October 3, 2020
A Machine-Learning Tool Concurrently Models Single Omics and Phenome Data for Functional Subtyping and Personalized Cancer MedicineGift Nyamundanda, Katherine Eason, Justin Guinney, et al.
Scientific Reports|May 24, 2024
Development and validation of a reliable DNA copy-number-based machine learning algorithm (CopyClust) for breast cancer integrative cluster classificationCameron C Young, Katherine Eason, Raquel Manzano Garcia, et al.
Scientific Reports|July 11, 2026
Breast cancer genomic subtype-specific copy number alterations in metastasesKatherine Eason, Christopher Boursnell, Raquel Manzano, et al.
Nature Communications|September 27, 2018
Microenvironmental niche divergence shapes BRCA1-dysregulated ovarian cancer morphological plasticityAndreas Heindl, Adnan Mujahid Khan, Daniel Nava Rodrigues, et al.
Molecular Oncology|April 22, 2025
Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic dataRong Zhu, Katherine Eason, Suet-Feung Chin, et al.
Scientific Reports|May 23, 2019
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular SubtypesChanthirika Ragulan, Katherine Eason, Elisa Fontana, et al.
ESMO Open|April 10, 2019
Benefit from anti-EGFRs in <i>RAS</i> and <i>BRAF</i> wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept studyChiara Cremolini, Matteo Benelli, Elisa Fontana, et al.
ESMO Open|September 24, 2020
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancerNoelia Tarazona, Francisco Gimeno-Valiente, Valentina Gambardella, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Research|September 17, 2016
Molecular or Metabolic Reprograming: What Triggers Tumor Subtypes?Katherine Eason, Anguraj Sadanandam
BMC Bioinformatics|May 27, 2018
polyClustR: defining communities of reconciled cancer subtypes with biological and prognostic significanceKatherine Eason, Gift Nyamundanda, Anguraj Sadanandam
Cancers|October 3, 2020
A Machine-Learning Tool Concurrently Models Single Omics and Phenome Data for Functional Subtyping and Personalized Cancer MedicineGift Nyamundanda, Katherine Eason, Justin Guinney, et al.
Scientific Reports|May 24, 2024
Development and validation of a reliable DNA copy-number-based machine learning algorithm (CopyClust) for breast cancer integrative cluster classificationCameron C Young, Katherine Eason, Raquel Manzano Garcia, et al.
Scientific Reports|July 11, 2026
Breast cancer genomic subtype-specific copy number alterations in metastasesKatherine Eason, Christopher Boursnell, Raquel Manzano, et al.
Nature Communications|September 27, 2018
Microenvironmental niche divergence shapes BRCA1-dysregulated ovarian cancer morphological plasticityAndreas Heindl, Adnan Mujahid Khan, Daniel Nava Rodrigues, et al.
Molecular Oncology|April 22, 2025
Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic dataRong Zhu, Katherine Eason, Suet-Feung Chin, et al.
Scientific Reports|May 23, 2019
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular SubtypesChanthirika Ragulan, Katherine Eason, Elisa Fontana, et al.
ESMO Open|April 10, 2019
Benefit from anti-EGFRs in <i>RAS</i> and <i>BRAF</i> wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept studyChiara Cremolini, Matteo Benelli, Elisa Fontana, et al.
ESMO Open|September 24, 2020
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancerNoelia Tarazona, Francisco Gimeno-Valiente, Valentina Gambardella, et al.
Pageof 2